An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules

A single-center, open-label dose-escalation design to evaluate the safety and efficacy of KN5001 in patients with pulmonary nodules.

Trial Details

NCT ID
NCT07185035
Phase
EARLY_PHASE1
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • KN5001
Locations (sample)
  • Nanjing, China|32.06167,118.77778

Key Eligibility Criteria

  • Subjects voluntarily sign the informed consent form, understand this clinical study, and are willing to follow and able to complete all trial proce…
  • 18-70 years old, male or female;
  • Subjects with lung nodules confirmed by imaging examination must meet the following conditions:
  • Multiple high-risk nodules have been surgically removed and confirmed to be malignant lesions, and the remaining high-risk nodules (refer to the st…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →